Aristolochic acid-induced accumulation of methylglyoxal and N ε-(carboxymethyl)lysine: An important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy

Biochemical and Biophysical Research Communications

Volumn 423, Issue 4, 2012, Pages 832-837

  Li, Yi Chieh ^a   Tsai, Shin Han ^b   Chen, Shih Ming ^a   Chang, Ya Min ^c   Huang, Tzu Chuan ^a   Huang, Yu Ping ^a   Chang, Chen Tien ^c   Lee, Jen Ai ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c PROVIDENCE UNIVERSITY   (Taiwan)

Author keywords

Advanced glycation end products; Aristolochic acid; Aristolochic acid nephropathy; Glutathione; Methylglyoxal; N (carboxymethyl)lysine

Indexed keywords

ARISTOLOCHIC ACID; GLUTATHIONE; LYSINE; METHYLGLYOXAL; N EPSILON (CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; KIDNEY DYSFUNCTION; KIDNEY HOMOGENATE; KIDNEY INJURY; KIDNEY TUBULE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ARISTOLOCHIC ACIDS; CREATINE; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY; LYSINE; MICE; MICE, INBRED C3H; NEPHRITIS, INTERSTITIAL; PYRUVALDEHYDE;

ARISTOLOCHIA; MUS;

EID: 84863835157     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.049     Document Type: Article

References (29)

1. Debelle F.D., Vanherweghem J.L., Nortier J.L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008, 74:158-169.
2. Vanherweghem J.L., Depierreux M., Tielemans C., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993, 341:387-391.
3. Arlt V.M., Stiborova M., Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002, 17:265-277.
4. Cosyns J.P. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Saf. 2003, 26:33-48.
5. Gold L.S., Slone T.H. Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N. Engl. J. Med. 2003, 349:1576-1577.
6. Cosyns J.P., Dehoux J.P., Guiot Y., et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?. Kidney Int. 2001, 59:2164-2173.
7. Wen Y.J., Qu L., Li X.M. Ischemic injury underlies the pathogenesis of aristolochic acid-induced acute kidney injury. Transl. Res. 2008, 152:38-46.
8. Lee J.M., Dedhar S., Kalluri R., et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell. Biol. 2006, 172:973-981.
9. Pozdzik A.A., Salmon I.J., Debelle F.D., et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 2008, 73:595-607.
10. Kalapos M.P. The tandem of free radicals and methylglyoxal. Chem. Biol. Interact. 2008, 171:251-271.
11. Vander Jagt D.L. Methylglyoxal, diabetes mellitus and diabetic complications. Drug Metab. Drug Interact. 2008, 23:93-124.
12. Meerwaldt R., Links T., Zeebregts C., et al. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc. Diabetol. 2008, 7:29.
13. Lou Y., Li J., Lu Y., et al. Aristolochic acid-induced destruction of organic ion transporters and fatty acid metabolic disorder in the kidney of rats. Toxicol. Lett. 2011, 201:72-79.
14. Yu F.Y., Wu T.S., Chen T.W., et al. Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. Toxicol. in Vitro 2011, 25:810-816.
15. Lee J.-A., Tsai Y.-C., Chen H.-Y., et al. Fluorimetric determination of d-lactate in urine of normal and diabetic rats by column-switching high-performance liquid chromatography. Anal. Chim. Acta 2005, 534:185-191.
16. Kaltwasser H., Schlegel H.G. NADH-dependent coupled enzyme assay for urease and other ammonia-producing systems. Anal. Biochem. 1966, 16:132-138.
17. Leaback D.H., Walker P.G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem. J. 1961, 78:151-156.
18. Espinosa-Mansilla A., Duran-Meras I., Canada F.C., et al. High-performance liquid chromatographic determination of glyoxal and methylglyoxal in urine by prederivatization to lumazinic rings using in serial fast scan fluorimetric and diode array detectors. Anal. Biochem. 2007, 371:82-91.
19. Gu C., Qu H., Han L., et al. The effect of raw soybean on oxidative status of digestive organs in mice. Int. J. Mol. Sci. 2011, 12:8836-8845.
20. Hsu D.Z., Wan C.H., Hsu H.F., Lin Y.M., Liu M.Y. The prophylactic protective effect of sesamol against ferric-nitrilotriacetate-induced acute renal injury in mice. Food Chem. Toxicol. 2008, 46:2736-2741.
21. Zheng F., Zhang X., Huang Q. Establishment of model of aristolochic acid-induced chronic renal interstitial fibrosis in rats. Zhonghua Yi Xue Za Zhi 2001, 81:1095-1100.
22. Debelle F.D., Nortier J.L., De Prez E.G., Garbar C.H., Vienne A.R., Salmon I.J., Deschodt-Lanckman M.M., Vanherweghem J.L. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 2002, 13:431-436.
23. Yang C.S., Lin C.H., Chang S.H., et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis. 2000, 35:313-318.
24. Chen M., Gong L., Qi X., et al. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity. Toxicol. Sci. 2011, 122:288-296.
25. Chen Y.Y., Chung J.G., Wu H.C., et al. Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells. Oncol. Rep. 2010, 24:141-153.
26. Zoccali C., Mallamaci F., Tripepi G. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol. Dial. Transplant. 2000, 15(Suppl 2):7-11.
27. Bakhiya N., Arlt V.M., Bahn A., et al. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology 2009, 264:74-79.
28. Vanherweghem J.L., Abramowicz D., Tielemans C., et al. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am. J. Kidney Dis. 1996, 27:209-215.
29. Debelle F.D., Nortier J.L., Husson C.P., et al. The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int. 2004, 66:1815-1825.